Skip to main content

Table 3 Prevalence of different types of chronic kidney disease and associated variables in the 1478 diabetic patients in wich CRI and albuminuria data were available

From: Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area

 

Albuminuria without renal impairment

Nonalbuminuric renal impairment

n,(%)

200 (13.5)

217 (14.7)

Age, mean (SD)

67.49 (11.89)

72.35 (9.94)a

Gender, men (%)

137 (68.5)

75 (34.6)a

Type 2 DM duration, years (SD)

7.13 (4.89)

8.41 (6.43)a

Obesity, n (%)

75 (44.4)

79 (39.3)a

BP, mmHg (SD)

139.79/77.79 (15.22/9.35)

138.12/75.38 (14.22/8.72)b

HbA1c, mean (SD)

7.27 (1.61)

6.68 (1.42)a

Total cholesterol, mean (SD)

187.74 (37.38)

193.17 (36.66)

Non-HDL cholesterol, mg/dl, mean (SD)

141.75 (34.89)

141.81 (35.75)

Creatinine, mg/dl (SD)

0.87 (0.17)

2.38 (1.60)a

GFR, mil/min/1.73 m 2 (SD)

92.49 (58.24)

36.55 (19.28)a

Tobacco, n (%)

34 (18.1)

15 (7.0)b

Macrovascular disease, n (%)

46 (23.8)

33 (15.4)a

CHD,n (%)

37 (19.2)

21 (9.8)a

Stroke, n (%)

10 (5.2)

15 (6.9)

Diabetic retinopathy, n (%)

23 (20.2)

25 (18.9)

Insulin treatment, n (%)

43 (22.0)

43 (19.9)

Calibrated Framingham CV risk eq. & 10%, n (%)

14 (10.4)

7 (6.3)

  1. BP: blood pressure; HDL: high density lipoprotein, GFR: glomerular filtration rate, CHD: coronary heart disease, CV: cardiovascular RI: renal impairment.
  2. Albuminuria without RI vs. Nonalbuminuric RI: a p <0.001; b p < 0.05.